🚨Commentary alert!🎵“Come together, right now…” As The Beatles sang: we comment on an approach to Base Editing of tumor-infiltrating lymphocytes (TILs)-the BE-TILs!😉Strategy with hit potential? www.cell.com/molecular-th... ..the earworm: rb.gy/20pxyz @moltherapy.bsky.social @dlwagnerlabs.bsky.social

Review @frontiersin.bsky.social @bextetobias.bsky.social Engineering with care: safety assessment platforms for CRISPR-modified NK cells www.frontiersin.org/journals/imm...

🚨Paper alert! Happy to share our review on safety assessments for gene-edited #NKcells. A highly timely topic for future multiplex-edited NK cells! Proud of my first senior authorship together with safety-tool expert Toni Cathomen. Congratulations to Alieh for fantastic work! tinyurl.com/4b4f6383

BIG ANNOUNCEMENT📣: I haven’t been this excited to be part of something new in 15 years… Thrilled to reveal the passion project I’ve been working on for the past year and a half!🙀🥳 (thread 👇)

@dlwagnerlabs.bsky.social on tour! 🌍🇩🇪🇺🇸 We had a great time at the Annual Congress of the European Society for Gene and Cell Therapy #ESGCT2025 in Sevilla. 🇪🇸 Super proud of everyone who presented their projects & grateful for working with this amazing team: science and good vibes! 🧬🧪💙

🚨 Paper alert! "Next-gen multiplex-edited CAR-NK cells: more edits, more power?" @jitc @bmj.com With @dlwagner.bsky.social we discuss Wang et al.’s landmark paper on multiplex base-edited non-viral CAR-NK cells. Promising efficiency but safety challenges! jitc.bmj.com/content/13/9...

🥳 #PaperAlert 🚨 Huge congrats to my lab-bestie Lisa Marie Reindl!! 💪🎉 So proud of you!😎🌟 EGFR-tarheting CAR NKcells in combination with radiotherapy showed significant tumor reduction ex vivo and in vivo in hard-to-treat solid tumors of rhabdomyosarcoma! jitc.bmj.com/content/13/7... @bmj.com